These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24944654)
1. Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter-1 and hypoxia-inducible-factor-1α and the phosphoinositide 3-kinase/protein kinase B pathway. Zhao K; Yang SY; Zhou SH; Dong MJ; Bao YY; Yao HT Oncol Lett; 2014 Apr; 7(4):984-990. PubMed ID: 24944654 [TBL] [Abstract][Full Text] [Related]
2. Effect of Glut-1 and HIF-1α double knockout by CRISPR/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K/Akt/mTOR pathway. Bao YY; Zhong JT; Shen LF; Dai LB; Zhou SH; Fan J; Yao HT; Lu ZJ J Cell Mol Med; 2022 May; 26(10):2881-2894. PubMed ID: 35415942 [TBL] [Abstract][Full Text] [Related]
3. Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and Shen LF; Zhou SH; Yu Q Transl Cancer Res; 2020 Apr; 9(4):2824-2837. PubMed ID: 35117639 [TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658 [TBL] [Abstract][Full Text] [Related]
5. Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma. Wu XH; Chen SP; Mao JY; Ji XX; Yao HT; Zhou SH Oncol Lett; 2013 Jan; 5(1):261-266. PubMed ID: 23255932 [TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-related markers in inflammatory myofibroblastic tumors of the head and neck. Wang KR; Jiang T; Wu TT; Zhou SH; Yao HT; Wang QY; Lu ZJ World J Surg Oncol; 2013 Nov; 11():294. PubMed ID: 24245510 [TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT. Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229 [TBL] [Abstract][Full Text] [Related]
8. Clinical features and hypoxic marker expression of primary sinonasal and laryngeal small-cell neuroendocrine carcinoma: a small case series. Chai L; Ying HF; Wu TT; Zhou SH; Bao YY; Yao HT; You QH World J Surg Oncol; 2014 Jul; 12():199. PubMed ID: 24980293 [TBL] [Abstract][Full Text] [Related]
9. Construction of a GLUT-1 and HIF-1α gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique. Lu ZJ; Yu Q; Zhou SH; Fan J; Shen LF; Bao YY; Wu TT; Zhou ML; Huang YP Cancer Manag Res; 2019; 11():2087-2096. PubMed ID: 30881132 [TBL] [Abstract][Full Text] [Related]
10. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma]. XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355 [TBL] [Abstract][Full Text] [Related]
11. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis. Starska K; Forma E; Jóźwiak P; Bryś M; Lewy-Trenda I; Brzezińska-Błaszczyk E; Krześlak A Tumour Biol; 2015 Apr; 36(4):2309-21. PubMed ID: 25412955 [TBL] [Abstract][Full Text] [Related]
12. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors. Xu H; Li B; Yu W; Wang H; Zhao X; Yao Y; Huang D Nucl Med Commun; 2013 Oct; 34(10):953-8. PubMed ID: 23887273 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphoinositide 3-kinase/Akt pathway decreases hypoxia inducible factor-1α expression and increases therapeutic efficacy of paclitaxel in human hypoxic gastric cancer cells. Zhang J; Guo H; Zhu JS; Yang YC; Chen WX; Chen NW Oncol Lett; 2014 May; 7(5):1401-1408. PubMed ID: 24765145 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro. Jiang T; Zhou ML; Fan J Onco Targets Ther; 2018; 11():7865-7872. PubMed ID: 30464533 [TBL] [Abstract][Full Text] [Related]
15. [Phosphoinositide 3-kinase/Akt pathway involved in regulation of hypoxia inducible factor 1alpha in hypoxia ischemia brain damage of neonatal rats]. Li L; Qu Y; Mao M; Mu D Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Sep; 22(9):1102-7. PubMed ID: 18822739 [TBL] [Abstract][Full Text] [Related]
17. The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988. Fan G; Bo J; Wan R; Peng M; Luan Y; Deng M; Xu L Cancer Biother Radiopharm; 2015 May; 30(4):160-8. PubMed ID: 25853522 [TBL] [Abstract][Full Text] [Related]
18. GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways. Burrows N; Babur M; Resch J; Ridsdale S; Mejin M; Rowling EJ; Brabant G; Williams KJ J Clin Endocrinol Metab; 2011 Dec; 96(12):E1934-43. PubMed ID: 21994956 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the association between HIF-1α and HER-2 expression, hormone receptor status, Ki-67 expression, histology and tumor FDG uptake in breast cancer. Cerci SM; Bozkurt KK; Eroglu HE; Cerci C; Erdemoglu E; Bulbul PT; Cetin M; Cetin R; Ciris IM; Bulbul M Oncol Lett; 2016 Nov; 12(5):3889-3895. PubMed ID: 27895745 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]